NO20061614L - Benzimidazolacetonitriler - Google Patents

Benzimidazolacetonitriler

Info

Publication number
NO20061614L
NO20061614L NO20061614A NO20061614A NO20061614L NO 20061614 L NO20061614 L NO 20061614L NO 20061614 A NO20061614 A NO 20061614A NO 20061614 A NO20061614 A NO 20061614A NO 20061614 L NO20061614 L NO 20061614L
Authority
NO
Norway
Prior art keywords
acetonitriles
benzimidazole
group
alkynyl
alkenyl
Prior art date
Application number
NO20061614A
Other languages
English (en)
Inventor
Jean-Pierre Gotteland
Pascale Gaillard
Matthias Schwarz
Patrick Page
Russell J Thomas
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20061614L publication Critical patent/NO20061614L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

Foreliggende oppfinnelse angår benzimidazolacetonitriler så vel som farmasøytiske formuleringer som inneholder slike benzimidazolacetonitriler med formel (I). Nevnte benzimidazolacetonitriler kan brukes for behandling av metabolske lidelser som er kontrollert eller forårsaket av insulinresistens eller hyperglykemi, og som omfatter diabetes II, utilfredsstillende glukosetoleranse, insulinresistens, overvekt og polycystisk eggstokksyndrom (PCOS) (I). Den foreliggende oppfinnelsen angår videre fremgangsmåter for fremstilling av benzimidazolacetonitriler, hvor G er pyrimidinyl, L er en aminogruppe eller en 3-8-leddet heterosykloalkylgruppe som inneholder minst ett heteroatom valgt fra N, O eller S, eller L er en acylaminogruppe; R1 er valgt fra gruppen bestående av hydrogen, sulfonyl, amino, karboksy, aminokarbonyl, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl eller C1-C6-alkoksy, aryl, halogen, cyano eller hydroksy; R2 er valgt fra gruppen bestående av hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, eller C1-C6-alkoksy.
NO20061614A 2003-09-12 2006-04-10 Benzimidazolacetonitriler NO20061614L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102741 2003-09-12
PCT/EP2004/052137 WO2005026155A1 (en) 2003-09-12 2004-09-10 Benzimidazole acetonitriles

Publications (1)

Publication Number Publication Date
NO20061614L true NO20061614L (no) 2006-04-10

Family

ID=34306922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061614A NO20061614L (no) 2003-09-12 2006-04-10 Benzimidazolacetonitriler

Country Status (7)

Country Link
EP (1) EP1667995A1 (no)
JP (1) JP2007505085A (no)
AU (1) AU2004272306A1 (no)
CA (1) CA2534317A1 (no)
IL (1) IL174135A0 (no)
NO (1) NO20061614L (no)
WO (1) WO2005026155A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713973B2 (en) 2004-10-15 2010-05-11 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
GEP20135728B (en) 2006-10-09 2013-01-25 Takeda Pharmaceuticals Co Kinase inhibitors
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN113281309B (zh) * 2021-05-17 2022-03-01 深圳市罗湖区人民医院 一种毒死蜱、多菌灵、阿特拉津三合一检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110957A1 (en) * 1999-12-24 2001-06-27 Applied Research Systems ARS Holding N.V. Benzazole derivatives and their use as JNK modulators
AU2001295026B2 (en) * 2000-09-06 2008-04-03 Novartis Vaccines And Diagnostics, Inc. Inhibitors of glycogen synthase kinase 3

Also Published As

Publication number Publication date
WO2005026155A1 (en) 2005-03-24
IL174135A0 (en) 2006-08-01
EP1667995A1 (en) 2006-06-14
AU2004272306A1 (en) 2005-03-24
CA2534317A1 (en) 2005-03-24
JP2007505085A (ja) 2007-03-08

Similar Documents

Publication Publication Date Title
NO20061614L (no) Benzimidazolacetonitriler
IL174250A0 (en) Use of benzothiazola derivatives for the preparation of medicament
NO20061599L (no) Benzoksazol acetonitriler
NO20091599L (no) Kjemiske forbindelser
NO20084005L (no) Aminderivater
ATE431345T1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
NO20063761L (no) Sulfonamidderivater for behandling av sykdommer
NO20080789L (no) 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
NO20080456L (no) Nye 2,4-dianilinopyrimidinderivater, fremstilling derav og deres anvendelse som medikamenter, farmasoytiske sammensetninger og, spesielt, som IKK inhibitorer
NO20064412L (no) Kondensert heterocykelderivat, medisinsk sammensetning inneholdende det samme og medisinsk anvendelse derav
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
DE602005013822D1 (de) Cycloalkylaminderivate
EA200870489A1 (ru) Пиперидинилзамещённые пирролидиноны в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы 1
ATE557030T1 (de) Kondensiertes heterocyclisches derivat, dieses enthaltende medizinische zusammensetzung und deren medizinische verwendung
NO20091596L (no) Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer
NO20072389L (no) Substituerte benzokinolizinderivater
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
CY1106857T1 (el) Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες
NO20092413L (no) Pyrazolanaloger
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
CY1107097T1 (el) 5ht4-ανταγωνιστικα βενζαμιδια 4-( αμινομεθυλ) - πιπεριδινης
NO20064806L (no) Formamidderivater anvendelige som adenoceptor
NO20076676L (no) Nye 8-sulfonyl-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptor
TH75318A (th) อนุพันธ์เบนซิมิดาโซล (Benzimidazole derivative) และการใช้ของมัน
DE602004029888D1 (en) Hydroxycarbonylphenyl substituierte 4-(aminomethyl)-piperidinbenzamide als 5ht4-antagonisten

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application